Bird & Bird represented Tilak Healthcare in the transaction, and Reed Smith and Jones Day represented the investors. Tilak Healthcare announced it has raised €10 million...
Tilak Healthcare’s €10 Million Funding Round
NovAliX’s Signature of a Strategic Collaboration Agreement with Galapagos
Bird & Bird is advising NovAliX in this transaction. Galapagos was advised by Baker & Mackenzie and Capstan. NovAliX, a leading integrated drug discovery company, and...
ImCheck Therapeutics’ €96 Million Fundraising
Dentons Paris advised ImCheck Therapeutics on the transaction. McDermott Will & Emery advised McDermott advised EarlyBird and Andera Partners. Goodwin advised Bpifrance. Bpifrance, through its InnoBio...
Meiogenix’s $13 Million Series A Financing Round
McDermott Will & Emery advised Meiogenix on the round. Meiogenix announced the closing of a USD 13 million (EUR 11 million) Series A financing round led...
Coave Therapeutics’ €21 Million Funding Round
IN BRIEF: Bird & Bird, McDermott Will & Emery, Weil, Gotshal & Manges, advised on the matter. Bird & Bird advised Coave Therapeutics (Horama SAS) with...
uniQure’s Acquisition of Corlieve Therapeutics
McDermott Will & Emery has advised Corlieve Therapeutics, while Morgan Lewis has advised uniQure on the deal. Corlieve Therapeutics completed its sale to uniQure, with its...